J&J/Janssen gain 1st US approval in MDR-TB with Sirturo

The US FDA and Janssen, a subsidiary of Johnson & Johnson, waited until the last day of 2012 to reveal regulators had granted an accelerated approval three days earlier to Sirturo (bedaquiline) as the first drug in the US to treat pulmonary multi-drug resistant tuberculosis (MDR-TB).